FDA Pediculicide Amendment Permits Detailed Insert Instructions
This article was originally published in The Tan Sheet
Executive Summary
Detailed use instructions for pediculicide products under the heading "Other information" may appear in a package insert, FDA states in a final amendment to the Pediculicide OTC Final Monograph, published in the Federal Register Dec. 31
You may also be interested in...
Pediculicide Detailed Use Instructions Belong On Package Insert – CHPA
Lengthy, detailed directions on environmental control of lice and combing to remove nits from hair need not be included on the outer label of OTC pediculicides, the Consumer Healthcare Products Association says
Pyrethrum Pediculicide Labeling Revisions Would Provide More Detail – FDA
FDA's proposed amendment of the pediculicide drug products final monograph would appear to bring labeling for such drugs in line with that of OTC lice treatments approved under an NDA
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC